Skip to main content
. 2022 Dec 2;29(12):9452–9460. doi: 10.3390/curroncol29120743

Figure 3.

Figure 3

(a) PFS and (b) OS in patients with B3 thymoma and non-squamous carcinoma. PFS did not differ between patients with B3 thymoma and non-squamous carcinoma (PFS, 11.3 vs. 6.5 months, p = 0.128). OS was different between patients with B3 thymoma and non-squamous carcinoma (OS, 58.3 vs. 30.6 months, p = 0.031).